dalteparin has been researched along with Celiac Sprue in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babanova, AV | 1 |
| Krums, LM | 1 |
| Bykova, SV | 1 |
| Parfenov, AI | 1 |
| Dudina, GA | 1 |
| Sabelnikova, EA | 1 |
| Khomeriki, SG | 1 |
| Lesko, KA | 1 |
| Dbar, SR | 1 |
1 other study available for dalteparin and Celiac Sprue
| Article | Year |
|---|---|
[Celiac crisis in patients with celiac disease. Case report].
Topics: Adult; Anti-Bacterial Agents; Atrophy; Celiac Disease; Child; Diet, Gluten-Free; Female; Humans; Mid | 2021 |